Searched for
PHARMACEUTICAL SECTORS
After E20 petrol, Nitin Gadkari pushes for 15% isobutanol-blended diesel: What it is and why it mattersIndia is set to embrace a new biofuel initiative, allowing up to 15% isobutanol blending with diesel. This strategic move aims to curb reli...- “Time has come to move from promise to practice”: Harsh Vardhan Shringla calls for India and Indonesia to match strategic intent with implementationSenior Indian policymakers and diplomats convened in New Delhi to explore deepening the India-Indonesia strategic partnership, ahead of the...
- Indian envoy pitches greater pharma exports, Chinese investment to deepen tiesIndia's ambassador to China, Vikram Doraiswami, stressed the importance of expanding access to Chinese markets for Indian pharmaceutical co...
- Markets may consolidate; micro, small and mid-caps could lead alpha generation, says Quant Mutual FundQuant Mutual Fund expects Indian equities to consolidate after the recent rally but believes micro-, small- and mid-cap stocks will drive a...
- Sitharaman urges French firms to invest in India's AI, clean energy pushUnion Finance Minister Nirmala Sitharaman urged French businesses to boost investments in India, highlighting vast opportunities in AI, cle...
- Military hardware, energy supply chains to fortify India-Japan tiesIndia and Japan have officially strengthened their strategic partnership, emphasizing initiatives aimed at economic security and collaborat...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- India-Japan Annual Summit to focus on AI, chips & clean energyThe two countries have identified semiconductors, critical minerals, pharmaceuticals, clean energy, and information and communication techn...
- Duty waiver on petrochemical products extended till July 15Indian manufacturers will continue to benefit from a full customs duty exemption on imported petrochemicals until July 15. This extension a...
- India's manufacturing growth slows in Q1 as West Asia conflict weighs: FICCIIndia's manufacturing sector anticipates a slower growth phase in the April-June quarter of FY27, influenced by the West Asia conflict. Whi...
- Govt extends customs duty waiver on import of key petrochemical products till July 15The government has extended the nil customs duty on approximately 40 critical petrochemical products by another 15 days, now until July 15....
- Manufacturing growth seen moderating in Q1 as West Asia crisis weighs on sentiment: FICCIIndia's manufacturing sector anticipates a slowdown in April-June FY27, influenced by West Asia tensions impacting business confidence. Des...
- Centre extends duty relief on key petrochemical products till July 15The government has extended the import duty exemption on about 40 key petrochemical products by 15 days, now until July 15. This move aims ...
- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Shelf-life norms for imported drugs may be relaxed to reduce wastageIndia is set to revise rules for imported medicines, proposing a 12-month minimum residual shelf life instead of the current 60% rule. This...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
Load More
